We subsequently assessed if the significant dysregulation of JADE2 could be linked to the mutational status of these genes in tumors, and again using TIMER2.0 we examined a number of genes commonly mutated in lung cancer to determine whether mutations within these key genes were correlated with altered JADE2 mRNA expression levels and the results are presented in Table 4. The gene discussed is JADE2; the disease is lung carcinoma.